Hikma Pharmaceuticals (HKMPY) Stock Price, News & Analysis

Company Overview

Hikma Pharmaceuticals PLC is a global pharmaceutical company headquartered in London, United Kingdom. Founded in 1978 by Samih Darwazah in Jordan, the company develops, manufactures and markets a broad range of prescription medicines for healthcare providers and patients.

Hikma operates through three principal businesses: Injectables, Generics and Branded Medicines. Its portfolio includes hospital injectable products, specialty and generic medicines, and branded pharmaceutical products in areas such as respiratory care, cardiovascular treatment, pain management, anti-infectives and central nervous system therapies. The company also provides ready-to-use and other specialized injectable formulations for hospitals and healthcare professionals.

The company serves markets across North America, the Middle East and North Africa, and Europe, with manufacturing, research and commercial operations in multiple countries. Hikma’s leadership is headed by Chief Executive Officer Siggi Olafsson, who became CEO in 2023.

Key Stats

• Today's Range: $42.03 to $42.22
• 50-Day Range: $41.31 to $46.21
• 52-Week Range: $31.80 to $49.31
• Volume: 349 shs
• Average Volume: 1,255 shs
• Market Capitalization: N/A
• P/E Ratio: 13.58
• Dividend Yield: 0.76%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:HKMPY
• CIK: N/A
• Web: www.hikma.com
• Phone: 442073992760
• Fax: N/A
• Employees: 9,400
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 13.58
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A